NCT01740063View on ClinicalTrials.gov

Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza

PHASE2CompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Influenza
Interventions
DRUG

DAS181-F02 formulation

DRUG

DAS181-F04 formulation

DRUG

Placebo

Trial Locations (1)

92121

Nexbio, San Diego

Sponsors
All Listed Sponsors
lead

Ansun Biopharma, Inc.

INDUSTRY